These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7560249)
1. The pharmacokinetics and cardiovascular pharmacodynamics of HP 749 (besipirdine HCl) and metabolite P86-7480 in the conscious monkey. Hubbard JW; Hsu RS; Griffiths L; Natarajan C; Dean R; Dileo EM; Hintze TH J Clin Pharmacol; 1995 Jul; 35(7):688-96. PubMed ID: 7560249 [TBL] [Abstract][Full Text] [Related]
2. alpha-Adrenergic activity and cardiovascular effects of besipirdine HCl (HP 749) and metabolite P7480 in vitro and in the conscious rat and dog. Hubbard JW; Nordstrom ST; Smith CP; Brooks KM; Laws-Ricker L; Zhou L; Vargas HM J Pharmacol Exp Ther; 1997 Apr; 281(1):337-46. PubMed ID: 9103515 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, metabolism and pharmacodynamics of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey. Kakiki M; Ishihara H Xenobiotica; 1998 Jan; 28(1):77-91. PubMed ID: 9493321 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and first clinical experiences with an antihypertensive dopamine (DA2) agonist. Meyer W; Bühring KU; Steiner K; Ungethüm W; Schnurr E Eur Heart J; 1992 Sep; 13 Suppl D():121-8. PubMed ID: 1356782 [TBL] [Abstract][Full Text] [Related]
5. Disposition of ropinirole in animals and man. Ramji JV; Keogh JP; Blake TJ; Broom C; Chenery RJ; Citerone DR; Lewis VA; Taylor AC; Yeulet SE Xenobiotica; 1999 Mar; 29(3):311-25. PubMed ID: 10219970 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of single intravenous and oral doses of dolasetron mesylate in healthy elderly volunteers. Dempsey E; Bourque S; Spénard J; Landriault H J Clin Pharmacol; 1996 Oct; 36(10):903-10. PubMed ID: 8930777 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral and intravenous dolasetron mesylate in patients with renal impairment. Dimmitt DC; Shah AK; Arumugham T; Cramer MB; Halstenson C; Horton M; Weir SJ J Clin Pharmacol; 1998 Sep; 38(9):798-806. PubMed ID: 9753207 [TBL] [Abstract][Full Text] [Related]
8. Clevidipine: a review of its use in the management of acute hypertension. Deeks ED; Keating GM; Keam SJ Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of nicorandil in humans: an overview. Frydman A J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S34-44. PubMed ID: 1282174 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of trimazosin in man. Reid JL; Meredith PA; Elliott HL Am Heart J; 1983 Nov; 106(5 Pt 2):1222-8. PubMed ID: 6637788 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of the ETA-selective endothelin receptor antagonist SPP301 in healthy human subjects. Dieterle W; Mann J; Kutz K J Clin Pharmacol; 2004 Jan; 44(1):59-66. PubMed ID: 14681342 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males. Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys. Siefert HM; Maruhn D; Maul W; Förster D; Ritter W Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211 [TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of triflusal and its main metabolite in rats and dogs. Ramis J; Mis R; Forn J Eur J Drug Metab Pharmacokinet; 1991; 16(4):261-8. PubMed ID: 1823869 [TBL] [Abstract][Full Text] [Related]
17. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
18. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures. Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of perindopril and its metabolites in healthy volunteers. Devissaguet JP; Ammoury N; Devissaguet M; Perret L Fundam Clin Pharmacol; 1990; 4(2):175-89. PubMed ID: 2351367 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]